LOADING
Comparing Johnson & Johnson (JNJ) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $582.0B | -- |
| P/E Ratio | 21.9 | -- |
| Forward P/E | 21.0 | -- |
| PEG Ratio | 1.69 | -- |
| EPS | $11.04 | -- |
| Revenue Growth (YoY) | 9.1% | -- |
| Profit Margin | 28.5% | -- |
| Return on Equity | 35.0% | -- |
| Dividend Yield | 2.12% | -- |
| Beta | 0.33 | -- |
| 52-Week High | $251.71 | -- |
| 52-Week Low | $137.67 | -- |
| Volume | -- | -- |